Sido Muncul Stock - Weekly review and sector context for Indonesia’s herbal producer

Edited by ad hoc news Sector & Peer-Group Desk. Verified prior to publication on 06/19/2026, 21:24 WIB. Details in the imprint.

Sido Muncul (ID1000126402) is one of Indonesia’s better-known traditional herbal medicine producers, listed on the Indonesia Stock Exchange in Jakarta. With no new investor-relations announcements or major analyst updates in recent days, the stock’s picture is shaped mainly by this week’s trading and the broader Indonesian consumer sector.

What this week shows

There has been no fresh press release on the investor-relations page of PT Industri Jamu dan Farmasi Sido Muncul Tbk in the past few days, and no new filings or corporate actions appear on the Indonesia Stock Exchange disclosure feed for the stock. That makes the past week’s trading mainly a function of broader Indonesian market sentiment and consumer-related news rather than company-specific headlines.

Indonesia’s main Jakarta Composite Index has recently traded in a restrained fashion, with modest daily point moves and no major macro shock. Consumer and healthcare-related names typically react to domestic consumption data and currency developments, but no big sector driver has emerged in the latest sessions.

Sector and peer-group comparison

Sido Muncul operates in the overlap of the consumer staples and healthcare segments, with a focus on traditional herbal remedies and supplements that are widely consumed in Indonesia. Within this niche, peers include other listed producers of jamu and over-the-counter remedies on the Indonesia Stock Exchange, which also cater to mass-market demand.

Compared with cyclical exporters or commodity producers on the Jakarta exchange, herbal and consumer-health companies often show more defensive revenue patterns, given stable domestic demand even when external conditions are volatile. For investors, weekly performance in such stocks is frequently less dramatic than in sectors tied directly to global commodity prices or external trade flows.

How the company makes money

PT Industri Jamu dan Farmasi Sido Muncul Tbk generates most of its revenue from the manufacture and sale of traditional herbal medicine, health drinks and supplements under its Sido Muncul brand portfolio. Flagship products include ready-to-drink herbal tonics and sachet-based jamu formulations that are distributed across Indonesia and selected export markets.

Where the stock trades today

The shares of Sido Muncul (ID1000126402) trade on the Indonesia Stock Exchange in Jakarta under the ticker SIDO in Indonesian rupiah; a reliably up-to-date quote and market capitalization are available on the official exchange and major financial data portals.

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.